Clay B. Siegall
2017
In 2017, Clay B. Siegall earned a total compensation of $8.6M as President and CEO at Seattle Genetics, a 10% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $934,500 |
|---|---|
| Option Awards | $3,217,921 |
| Salary | $887,146 |
| Stock Awards | $3,561,064 |
| Other | $15,713 |
| Total | $8,616,344 |
Siegall received $3.6M in stock awards, accounting for 41% of the total pay in 2017.
Siegall also received $934.5K in non-equity incentive plan, $3.2M in option awards, $887.1K in salary and $15.7K in other compensation.
Rankings
In 2017, Clay B. Siegall's compensation ranked 834th out of 14,666 executives tracked by ExecPay. In other words, Siegall earned more than 94.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 834 out of 14,666 | 94th |
Division Manufacturing | 281 out of 5,772 | 95th |
Major group Chemicals And Allied Products | 71 out of 2,075 | 97th |
Industry group Drugs | 51 out of 1,731 | 97th |
Industry Biological Products, Except Diagnostic Substances | 9 out of 313 | 97th |
Source: SEC filing on April 3, 2018.
Siegall's colleagues
We found seven more compensation records of executives who worked with Clay B. Siegall at Seattle Genetics in 2017.
2017
Eric Dobmeier
Seattle Genetics
Chief Operating Officer
2017
Jonathan Drachman
Seattle Genetics
Chief Medical Officer
2017
Todd Simpson
Seattle Genetics
Chief Financial Officer
2017
Vaughn Himes
Seattle Genetics
Chief Technical Officer
2017
Jean Liu
Seattle Genetics
General Counsel
2017
Jean Liu
Seattle Genetics
General Counsel
2017
Darren Cline
Seattle Genetics